This inventor holds 5 USPTO granted patents and 7 published patent applications and 5 EPO patents. Top assignee: Korea Institute of Science and Technology. Active years: 2010-2023.
Company Filing History:
Years Active: 2010-2023
Title: Dae-Ro Ahn: Innovator in Nucleic Acid Nanoparticles
Introduction
Dae-Ro Ahn is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of drug delivery systems through his innovative research and development. With a total of 5 patents to his name, Ahn is recognized for his groundbreaking work in the creation of three-dimensional self-assembled nucleic acid nanoparticles.
Latest Patents
One of his latest patents is titled "Three-dimensional self-assembled nucleic acid nanoparticles and use thereof." This invention relates to a drug delivery system that utilizes tetrahedral nucleic acid nanoparticles. These nanoparticles exhibit excellent renal-targeting ability, making them suitable for the prevention or treatment of acute kidney injury. The nanoparticles, when conjugated with pharmaceutically active ingredients, demonstrate significant reductions in p53 and caspase 3 expression both in vitro and in vivo.
Another notable patent is "Drug carrier having L-DNA nanocage structure." This invention involves a drug carrier constructed using L-DNA, which is the mirror form of natural DNA. The L-DNA nanocage structure provides superior cellular uptake efficiency and serum stability, allowing for effective drug delivery into cells.
Career Highlights
Dae-Ro Ahn is affiliated with the Korea Institute of Science and Technology, where he conducts his research. His work has garnered attention for its potential applications in medical treatments and drug delivery systems. Ahn's innovative approach to utilizing nucleic acid nanoparticles positions him as a leader in his field.
Collaborations
Ahn has collaborated with notable colleagues, including Eun Gyeong Yang and Dongyun Shin. Their combined expertise has contributed to the advancement of research in nucleic acid-based drug delivery systems.
Conclusion
Dae-Ro Ahn's contributions to the field of drug delivery through his innovative patents highlight his role as a key inventor in the scientific community. His work continues to pave the way for advancements in medical treatments and drug delivery technologies.